Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home Search
cancer - search results
If you're not happy with the results, please do another search
The complexities of understanding the consequences of air pollution on human health
Dr. Francisco Inesta-Vaquera, Dr. Colin Henderson, Professor Jonathan Grigg and Professor C. Roland Wolf from the Universities of Dundee and London discuss the complexities of understanding the consequences of air pollution on human health.
Whole genome sequencing: It’s getting personal
Professors Darren K Griffin and Alan R Thornhill discuss their research on exploring a person’s genome sequencing.
The role of vitamin D in pregnancy
Dr Larisa Corda Obstetrician and Gynaecologist shares her expert thoughts here on the role of vitamin D in pregnancy.
Distributive biobanking models: Why biospecimens need blockchain
Here, several experts from the International Society for Biological and Environmental Repositories provide a novel perspective around distributive biobanking models, including why biospecimens need blockchain.
Climate toxicology: The impact on human health
Eduardo A. González, B.S. and Pamela J. Lein, Ph.D., University of California, Davis discuss how global climate change is increasing toxicological impacts on human health.
An update on the medical technology sector
Andrew Davies, Digital Health Lead at ABHI provides an important update on the latest developments in the medical technology sector.
Dr Elizabeth Robertson – Diabetes UK
Dr Elizabeth Johnson is Director of Research and joined Diabetes UK in April 2016.
The cardiovascular disease burden from ambient air pollution in Europe
Thomas Münzel MD, Andreas Daiber PhD, Ulrich Pöschl PhD and Jos Lelieveld PhD discuss the link between air pollution and cardiovascular disease in Europe.
Cybersecurity in hospitals and care centres
Dr Peter Leitner and Stela Shiroka, at INTERSPREAD GmbH, detail cybersecurity in hospitals and care centres and their thoughts on the need for increased awareness and enhanced training capabilities in Europe.
Current gaps and future opportunities in dementia research
Here, Hilary Evans, Chief Executive at Alzheimer’s Research UK, outlines the current gaps and future opportunities in dementia research.
Medical marijuana: Developments in the industry
Ian C Tordoff, CEO of Block Commodities Ltd, provides a snap-shot of changes in the medical marijuana industry.
Vessel growth in health and disease
John Greenwood PhD FRCPath and Stephen E. Moss PhD from UCL Institute of Ophthalmology discuss the vasculature in health and disease, a major focus of their research.
Functional nanomaterials: Fit for purpose
Researchers at Técnico, Univ. Lisboa, share their expertise on functional nanomaterials and why they are fit for purpose.
Scientists discover way to protect hair from chemotherapy
Scientists have determined a new way to protect the hair follicle from chemotherapy in an effort to prevent hair loss as a result of cancer treatments.
Jean-Marie Dangou – WHO Regional Office for Africa
Jean-Marie Dangou has an international reputation for his work in Noncommunicable diseases (NCDs) and cancer in particular.
UK launches £200 million genetics project
The UK government announced the launch of a huge genetics project, working with GlaxoSmithKline and AstraZeneca, to understand diseases like dementia and cancer.
EU: Who are the new European Commissioners?
Here, we discuss the freshly elected European Commissioners of the 2019-2024 period, including their duties and a vision of the EU their work attempts to shape.
Precision medicine: Cost-effectiveness of breakthrough treatments
Dr Gerry Morrow shares his thoughts on the precision medicine, defined as the cost-effectiveness of breakthrough treatments and explains why this area is a priority for both researchers and government.
What are the data protection challenges of using AI in healthcare?
This article considers the increasing political interest in the use of Artificial Intelligence (AI) in healthcare and considers how data protection legislation may help to build greater understanding and trust.
Assessing nanomaterials health risks in the workplace
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group assesses nanomaterials health risks in the workplace, starting with an overall perspective on the topic that includes risk assessment policies.
